High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy

Verfasser / Beitragende:
[F. De Marco, R. Liguori, M. G. Giardina, M. D'Armiento, E. Angelucci, A. Lucariello, R. Morante, L. Cimino, A. Galeota-Lanza, G. Tarantino, A. Ascione, G. Budillon, R. Vecchione, R. Martinelli, M. Matarazzo, V. De Simone]
Ort, Verlag, Jahr:
2004
Enthalten in:
Clinical Chemistry and Laboratory Medicine, 42/1(2004-02-16), 17-24
Format:
Artikel (online)
ID: 378897985
LEADER caa a22 4500
001 378897985
003 CHVBK
005 20180305123511.0
007 cr unu---uuuuu
008 161128e20040216xx s 000 0 eng
024 7 0 |a 10.1515/CCLM.2004.005  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2004.005 
245 0 0 |a High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy  |h [Elektronische Daten]  |c [F. De Marco, R. Liguori, M. G. Giardina, M. D'Armiento, E. Angelucci, A. Lucariello, R. Morante, L. Cimino, A. Galeota-Lanza, G. Tarantino, A. Ascione, G. Budillon, R. Vecchione, R. Martinelli, M. Matarazzo, V. De Simone] 
520 3 |a Hereditary haemochromatosis is an autosomal recessive disorder of iron regulation that results in abnormal intestinal iron absorption with progressive iron overloading of parenchymal cells. Two specific, single point mutations of the HFE gene (C282Y and H63D) have been described in haemochromatosis patients. Epidemiological studies have revealed a strict association between hereditary haemochromatosis and C282Y homozygosis or C282Y/H63D compound heterozygosis, suggesting that these mutations may provide a useful tool for diagnosis. However, recent investigations from southern Europe have reported lower allelic frequencies of the C282Y mutation among haemochromatosis patients, apparently depending on the geographical area of the population analysed. To assess the predictive value of the detection of the C282Y and H63D HFE mutations in our geographical area, we have evaluated their occurrence in 46 haemochromatosis patients from southern Italy. We found that only 19.6% of our patients were homozygous for the C282Y mutation and 21.7% were compound C282Y/H63D heterozygotes. Among the remaining 59%, approximately 40% did not display any of the known HFE mutations. We conclude that, in southern Italy, another genetic determinant/s must be responsible for many haemochromatosis cases and that a genetic screening for the C282Y and H63D HFE mutations is not sufficient for hereditary haemochromatosis diagnosis. 
540 |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Medical equipment & techniques  |2 nationallicence 
690 7 |a Medical diagnosis  |2 nationallicence 
690 7 |a Diseases & disorders  |2 nationallicence 
700 1 |a Marco  |D F. De  |4 aut 
700 1 |a Liguori  |D R.  |4 aut 
700 1 |a Giardina  |D M. G.  |4 aut 
700 1 |a D'Armiento  |D M.  |4 aut 
700 1 |a Angelucci  |D E.  |4 aut 
700 1 |a Lucariello  |D A.  |4 aut 
700 1 |a Morante  |D R.  |4 aut 
700 1 |a Cimino  |D L.  |4 aut 
700 1 |a Galeota-Lanza  |D A.  |4 aut 
700 1 |a Tarantino  |D G.  |4 aut 
700 1 |a Ascione  |D A.  |4 aut 
700 1 |a Budillon  |D G.  |4 aut 
700 1 |a Vecchione  |D R.  |4 aut 
700 1 |a Martinelli  |D R.  |4 aut 
700 1 |a Matarazzo  |D M.  |4 aut 
700 1 |a Simone  |D V. De  |4 aut 
773 0 |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 42/1(2004-02-16), 17-24  |x 1434-6621  |q 42:1<17  |1 2004  |2 42  |o cclm 
856 4 0 |u https://doi.org/10.1515/CCLM.2004.005  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/CCLM.2004.005  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Marco  |D F. De  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Liguori  |D R.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Giardina  |D M. G.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a D'Armiento  |D M.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Angelucci  |D E.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Lucariello  |D A.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Morante  |D R.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cimino  |D L.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Galeota-Lanza  |D A.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tarantino  |D G.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ascione  |D A.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Budillon  |D G.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Vecchione  |D R.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Martinelli  |D R.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Matarazzo  |D M.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Simone  |D V. De  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 42/1(2004-02-16), 17-24  |x 1434-6621  |q 42:1<17  |1 2004  |2 42  |o cclm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter